Lisa D. Laury‐Kleintop

Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound <scp>d</scp> -1-Methyl-Tryptophan

Richard Metz, James B. DuHadaway, Uma Kamasani et al. · Cancer Research · 2007 · 459 citations · Full text

IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development

Courtney Smith, Mee Young Chang, Katherine H. Parker et al. · Cancer Discovery · 2012 · 319 citations · Full text

The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells

Sara Trabanelli, Darina Očadlíková, Marilena Ciciarello et al. · The Journal of Immunology · 2014 · 67 citations · Full text

RhoB Regulates PDGFR-β Trafficking and Signaling in Vascular Smooth Muscle Cells

Minzhou Huang, James B. DuHadaway, George C. Prendergast et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 63 citations · Full text

Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model

Robert J. Andrew, Pierre De Rossi, Phuong Nguyen et al. · Journal of Biological Chemistry · 2019 · 60 citations · Full text